600511 国药股份
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(3,592,951)2,005,5181,659,1202,726,6572,395,123
投资活动产生之现金流量净额(3,321)(17,389)(2,583,710)(129,311)(152,319)
筹资活动产生之现金流量净额(86,664)(1,387,477)(1,582,333)(632,176)(639,573)
汇率变动对现金及现金等价物的影响----------
现金及现金等价物净增加/(减少)(3,682,936)600,652(2,506,924)1,965,1701,603,232
期初现金及现金等价物余额8,892,0468,291,39410,798,3188,833,1487,229,916
期末现金及现金等价物余额5,209,1108,892,0468,291,39410,798,3188,833,148